article · Microbes and Infectious Diseases /Microbes and Infectious Diseases
Background: The emergence and worldwide circulation of strains of beta-lactamase-producing Enterobacterales represent a major public health problem. The aim of this study was the characterization of extended spectrum beta-lactamase (ESBL) and carbapenemase-producing strains of Escherichia coli and Klebsiella pneumoniae resistant strains isolated in Kinshasa hospitals. Methods: Urine samples were collected from hospitalized and non-hospitalized patients. Bacteria were identified by using conventional biochemical tests and MALDI-TOF. Antibiotic susceptibility testing was performed by disk diffusion method. ESBL and carbapenemase phenotypes were screened using standard microbiological tests. ESBL-encoding genes were tested by multiplex end-point PCR assays and carbapenemase enzymes were identified by immunochromatography assay. Results: Out of 286 urines, 200 (69.9%) Gram negative bacteria were isolated, among them 70 (35.0 %) E. coli and 23 (11.5%) K. pneumoniae. ESBL were identified in 62.9 % (44/70) and in 52.2% (12/23) of E. coli and K. pneumoniae strains respectively. The rate of ESBL-producing Enterobacterales was 60.2% (56/93). Among ESBL producers, the blaCTX-M1 gene was identified in 88.6 % (39/44) isolates of E. coli and in 100% (12/12) isolates of K. pneumoniae. The bla-gene blaCTX-M-1 was identified in 91.2% (51/56) of all ESBL producers strains. Only 3.2% (3/93) of Enterobacterales strains produced the NDM enzyme. The Other genes encoding beta-lactamase were blaTEM (64.3 %), blaOXA-1/-30 (58.9 %), and blaSHV (39.3%). Conclusion: A high rate of ESBL-producing Enterobacterales was observed. The results of the study report the first description of metallo-β-lactamase NDM producing E. coli and K. pneumoniae strains from patients in Democratic Republic of Congo.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/mid.2024.329996.2301
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.